Abstract
Clozapine is the only medication approved for both treatment resistant schizophrenia and suicidal behavior in patients with schizophrenia or schizoaffective disorder. Of note, 16.3% of male veterans with schizophrenia die by suicide. However, despite its proven efficacy, clozapine has consistently been underutilized in the US. We therefore examined the extent of clozapine prescribing in the Veterans Health Administration (VHA), the largest integrated health care system in the US.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
